Cannell & Co. Regeneron Pharmaceuticals, Inc. Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cannell & Co. holds 10,742 shares of REGN stock, worth $6.48 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

10,742

Previous 10,917 1.6%

Holding current value

$6.48 Million

Previous $8.98 Million 5.01%

% of portfolio

0.31%

Previous 0.32%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$775.18 - $881.7 $135,656 - $154,297	-175 Reduced 1.6%	10,742 $9.43 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $6,924 - $8,443	-10 Reduced 0.09%	10,917 $8.98 Million
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $56,002 - $66,428	80 Added 0.74%	10,927 $7.85 Million
Q1 2023 May 08, 2023	SELL	$680.49 - $826.97 $973,781 - $1.18 Million	-1,431 Reduced 11.65%	10,847 $8.91 Million
Q4 2022 Feb 03, 2023	BUY	$705.89 - $766.39 $16,235 - $17,626	23 Added 0.19%	12,278 $8.86 Million
Q3 2022 Nov 02, 2022	SELL	$573.97 - $724.32 $18,941 - $23,902	-33 Reduced 0.27%	12,255 $8.44 Million
Q2 2022 Aug 08, 2022	SELL	$548.35 - $738.84 $110,766 - $149,245	-202 Reduced 1.62%	12,288 $7.26 Million
Q1 2022 May 10, 2022	SELL	$595.12 - $698.43 $38,682 - $45,397	-65 Reduced 0.52%	12,490 $8.72 Million
Q4 2021 Feb 09, 2022	SELL	$543.48 - $670.97 $290,761 - $358,968	-535 Reduced 4.09%	12,555 $7.93 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $51,088 - $60,605	89 Added 0.68%	13,090 $7.92 Million
Q2 2021 Aug 09, 2021	SELL	$472.8 - $558.54 $2,364 - $2,792	-5 Reduced 0.04%	13,001 $7.26 Million
Q1 2021 May 07, 2021	SELL	$446.73 - $548.2 $4.33 Million - $5.32 Million	-9,700 Reduced 42.72%	13,006 $6.15 Million
Q4 2020 Feb 11, 2021	BUY	$478.3 - $607.98 $4.53 Million - $5.75 Million	9,461 Added 71.43%	22,706 $11 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $162,880 - $196,804	299 Added 2.31%	13,245 $7.41 Million
Q2 2020 Aug 07, 2020	SELL	$493.32 - $643.92 $11 Million - $14.3 Million	-22,276 Reduced 63.24%	12,946 $8.07 Million
Q1 2020 May 05, 2020	SELL	$336.18 - $494.43 $144,893 - $213,099	-431 Reduced 1.21%	35,222 $17.2 Million
Q4 2019 Feb 10, 2020	BUY	$274.13 - $376.51 $6.54 Million - $8.98 Million	23,857 Added 202.25%	35,653 $13.7 Million
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $1.36 Million - $1.59 Million	-4,985 Reduced 29.71%	11,796 $3.27 Million
Q2 2019 Aug 12, 2019	SELL	$299.6 - $414.82 $6.34 Million - $8.78 Million	-21,177 Reduced 55.79%	16,781 $5.25 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $2.56 Million - $3.02 Million	-6,869 Reduced 15.32%	37,958 $15.6 Million
Q4 2018 Feb 11, 2019	SELL	$335.82 - $403.04 $347,909 - $417,549	-1,036 Reduced 2.26%	44,827 $16.7 Million
Q3 2018 Nov 05, 2018	BUY	$351.14 - $408.51 $4.62 Million - $5.37 Million	13,147 Added 40.19%	45,863 $18.5 Million
Q2 2018 Aug 06, 2018	BUY	$284.6 - $344.99 $9.03 Million - $10.9 Million	31,736 Added 3238.37%	32,716 $11.3 Million
Q1 2018 May 09, 2018	BUY	$315.82 - $393.78 $309,503 - $385,904	980 New	980 $337,000

Others Institutions Holding REGN

# of Institutions

1,475

Shares Held

87.4M

Call Options Held

1.51M

Put Options Held

1.42M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $64.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account